Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

GI Cancers-Modulating the Modern Management of Gastrointestinal Malignancies: A Look at Liver Metastases, Rectal Cancer, Esophagogastric Cancer, and Anal Cancer.

Jabbour SK, Apisarnthanarax S, Hallemeier CL, Huguet F, Murphy JD, Olsen JR.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):749-758. doi: 10.1016/j.ijrobp.2017.11.031. Epub 2018 Jun 20. No abstract available.

PMID:
29976479
2.

Cross-Modality Comparisons Between Radiofrequency Ablation and Stereotactic Body Radiotherapy for Treatment of Hepatocellular Carcinoma: Limitations of the National Cancer Database.

Olsen JR, Murphy JD, Hallemeier CL, Apisarnthanarax S, Huguet F, Jabbour SK.

J Clin Oncol. 2018 Jun 26:JCO2018782904. doi: 10.1200/JCO.2018.78.2904. [Epub ahead of print] No abstract available.

PMID:
29945521
3.

Efficient double-scattering proton therapy with a patient-specific bolus.

Zou W, Burgdorf B, Yue NJ, Yin L, Zhang M, Khan A, Jabbour SK, McDonough J, Dong L, Teo BK.

Phys Med. 2018 Jun;50:1-6. doi: 10.1016/j.ejmp.2018.05.003. Epub 2018 May 26.

PMID:
29891088
4.

Dosimetric Predictors of Symptomatic Cardiac Events after Conventional-Dose Chemoradiation Therapy for Inoperable Non-Small Cell Lung Cancer.

Yegya-Raman N, Wang K, Kim S, Reyhan M, Deek MP, Sayan M, Li D, Patel M, Malhotra J, Aisner J, Marks LB, Jabbour SK.

J Thorac Oncol. 2018 Jun 5. pii: S1556-0864(18)30675-0. doi: 10.1016/j.jtho.2018.05.028. [Epub ahead of print]

PMID:
29883836
5.

Patient-related outcomes with the use of checkpoint inhibitors for the treatment of metastatic non-small cell lung cancer.

Malhotra J, Jabbour SK.

Transl Lung Cancer Res. 2018 Apr;7(Suppl 2):S138-S141. doi: 10.21037/tlcr.2018.03.09. No abstract available.

6.

Management of locally advanced rectal cancer in the elderly: a critical review and algorithm.

Hathout L, Maloney-Patel N, Malhotra U, Wang SJ, Chokhavatia S, Dalal I, Poplin E, Jabbour SK.

J Gastrointest Oncol. 2018 Apr;9(2):363-376. doi: 10.21037/jgo.2017.10.10. Review.

7.

Predictors of Survival after Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases.

Weiner AA, Gui B, Newman NB, Nosher JL, Yousseff F, Lu SE, Foltz GM, Carpizo D, Lowenthal J, Zuckerman DA, Benson B, Olsen JR, Jabbour SK, Parikh PJ.

J Vasc Interv Radiol. 2018 May 10. pii: S1051-0443(18)30960-6. doi: 10.1016/j.jvir.2018.02.020. [Epub ahead of print]

PMID:
29754852
8.

Variations in Initiation Dates of Chemotherapy and Radiation Therapy for Definitive Management of Inoperable Non-Small Cell Lung Cancer Are Associated With Decreases in Overall Survival.

Deek MP, Kim S, Beck R, Yegya-Raman N, Langenfeld J, Malhotra J, Mahmoud O, Aisner J, Jabbour SK.

Clin Lung Cancer. 2018 Jul;19(4):e381-e390. doi: 10.1016/j.cllc.2018.03.007. Epub 2018 Mar 17.

PMID:
29752011
9.

Daily Image Guidance With Cone Beam Computed Tomography May Reduce Radiation Pneumonitis in Unresectable Non-Small Cell Lung Cancer.

Yegya-Raman N, Kim S, Deek MP, Li D, Gupta A, Bond L, Dwivedi A, Braver JK, Reyhan M, Mittal A, Gui B, Malhotra J, Aisner J, Jabbour SK.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1104-1112. doi: 10.1016/j.ijrobp.2018.03.025. Epub 2018 Mar 30.

PMID:
29730063
10.

Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer.

Huang Q, Jabbour SK, Xiao Z, Yue N, Wang X, Cao H, Kuang Y, Zhang Y, Nie K.

Radiat Oncol. 2018 Apr 25;13(1):78. doi: 10.1186/s13014-018-1018-x.

11.

Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer.

Newman JH, Augeri DJ, NeMoyer R, Malhotra J, Langenfeld E, Chesson CB, Dobias NS, Lee MJ, Tarabichi S, Jhawar SR, Bommareddy PK, Marshall S, Sadimin ET, Kerrigan JE, Goedken M, Minerowicz C, Jabbour SK, Li S, Carayannopolous MO, Zloza A, Langenfeld J.

Oncogene. 2018 Jul;37(27):3672-3685. doi: 10.1038/s41388-018-0156-9. Epub 2018 Apr 6.

PMID:
29622797
12.

Decision-Making Strategy for Rectal Cancer Management Using Radiation Therapy for Elderly or Comorbid Patients.

Wang SJ, Hathout L, Malhotra U, Maloney-Patel N, Kilic S, Poplin E, Jabbour SK.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):926-944. doi: 10.1016/j.ijrobp.2017.12.261. Review.

PMID:
29485072
13.

The Impact of Novel Radiation Treatment Techniques on Toxicity and Clinical Outcomes In Rectal Cancer.

Hathout L, Williams TM, Jabbour SK.

Curr Colorectal Cancer Rep. 2017 Feb;13(1):61-72. doi: 10.1007/s11888-017-0351-z. Epub 2017 Mar 10.

14.

Using gEUD based plan analysis method to evaluate proton vs. photon plans for lung cancer radiation therapy.

Xiao Z, Zou WJ, Chen T, Yue NJ, Jabbour SK, Parikh R, Zhang M.

J Appl Clin Med Phys. 2018 Mar;19(2):204-210. doi: 10.1002/acm2.12281. Epub 2018 Feb 13.

15.

Automated Information Extraction on Treatment and Prognosis for Non-Small Cell Lung Cancer Radiotherapy Patients: Clinical Study.

Zheng S, Jabbour SK, O'Reilly SE, Lu JJ, Dong L, Ding L, Xiao Y, Yue N, Wang F, Zou W.

JMIR Med Inform. 2018 Feb 1;6(1):e8. doi: 10.2196/medinform.8662.

16.

Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant Chemoradiation.

Herman JM, Jabbour SK, Lin SH, Deek MP, Hsu CC, Fishman EK, Kim S, Cameron JL, Chekmareva M, Laheru DA, Narang AK, Pawlik TM, Hruban RH, Wolfgang CL, Iacobuzio-Donahue CA.

Pancreas. 2018 Feb;47(2):208-212. doi: 10.1097/MPA.0000000000000985.

PMID:
29329157
17.

Gastrointestinal Cancers: Timing Is Everything.

Apisarnthanarax S, Jabbour SK, Liauw SL, Murphy JD, Olsen JR, Chang DT.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1051-1058. doi: 10.1016/j.ijrobp.2017.05.040. No abstract available.

PMID:
29165271
18.

Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery.

Ma R, Levy M, Gui B, Lu SE, Narra V, Goyal S, Danish S, Hanft S, Khan AJ, Malhotra J, Motwani S, Jabbour SK.

J Neurooncol. 2018 Jan;136(2):395-401. doi: 10.1007/s11060-017-2666-7. Epub 2017 Nov 20.

PMID:
29159778
19.

Erratum to current state of immunotherapy for non-small cell lung cancer.

Malhotra J, Jabbour SK, Aisner J.

Transl Lung Cancer Res. 2017 Oct;6(5):612. doi: 10.21037/tlcr.2017.08.08.

20.

Bone marrow tolerance during postoperative chemotherapy in colorectal carcinomas.

Newman NB, Moss RA, Maloney-Patel N, Donohue K, Brown TV, Nissenblatt MJ, Lu SE, Jabbour SK.

J Gastrointest Oncol. 2017 Jun;8(3):547-555. doi: 10.21037/jgo.2017.01.19.

21.

Current state of immunotherapy for non-small cell lung cancer.

Malhotra J, Jabbour SK, Aisner J.

Transl Lung Cancer Res. 2017 Apr;6(2):196-211. doi: 10.21037/tlcr.2017.03.01. Review. Erratum in: Transl Lung Cancer Res. 2017 Oct;6(5):612.

22.

Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer.

Jabbour SK, Berman AT, Simone CB 2nd.

Transl Lung Cancer Res. 2017 Apr;6(2):113-118. doi: 10.21037/tlcr.2017.04.02. Review.

23.

Harnessing the potential synergy of combining radiation therapy and immunotherapy for thoracic malignancies.

Simone CB 2nd, Berman AT, Jabbour SK.

Transl Lung Cancer Res. 2017 Apr;6(2):109-112. doi: 10.21037/tlcr.2017.04.05. No abstract available.

24.

Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series.

Hadzitheodorou C, Moss RA, Kennedy TJ, Jabbour SK.

Case Rep Oncol. 2017 Apr 4;10(1):308-315. doi: 10.1159/000464280. eCollection 2017 Jan-Apr.

25.

Utilization pattern and survival outcomes of adjuvant therapies in high-grade nonretroperitoneal abdominal soft tissue sarcoma: A population-based study.

Green WR, Chokshi R, Jabbour SK, DeLaney TF, Mahmoud O.

Asia Pac J Clin Oncol. 2018 Feb;14(1):101-113. doi: 10.1111/ajco.12683. Epub 2017 May 2.

PMID:
28464497
26.

Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization.

Gui B, Weiner AA, Nosher J, Lu SE, Foltz GM, Hasan O, Kim SK, Gendel V, Mani NB, Carpizo DR, Saad NE, Kennedy TJ, Zuckerman DA, Olsen JR, Parikh PJ, Jabbour SK.

Am J Clin Oncol. 2017 Apr 17. doi: 10.1097/COC.0000000000000384. [Epub ahead of print]

PMID:
28418940
27.

Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis.

Verma V, Shostrom VK, Zhen W, Zhang M, Braunstein SE, Holland J, Hallemeier CL, Harkenrider MM, Iskhanian A, Jabbour SK, Attia A, Lee P, Wang K, Decker RH, McGarry RC, Simone CB 2nd.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):778-785. doi: 10.1016/j.ijrobp.2016.11.049. Epub 2016 Dec 2.

PMID:
28244414
28.

ACR Appropriateness Criteria® Resectable Pancreatic Cancer.

Jones WE 3rd, Suh WW, Abdel-Wahab M, Abrams RA, Azad N, Das P, Dragovic J, Goodman KA, Jabbour SK, Konski AA, Koong AC, Kumar R, Lee P, Pawlik TM, Small W Jr, Herman JM; Expert Panel on Radiation OncologyGastrointestinal.

Am J Clin Oncol. 2017 Apr;40(2):109-117. doi: 10.1097/COC.0000000000000370. Review.

PMID:
28230650
29.

Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer.

Verma V, Simone CB 2nd, Allen PK, Gajjar SR, Shah C, Zhen W, Harkenrider MM, Hallemeier CL, Jabbour SK, Matthiesen CL, Braunstein SE, Lee P, Dilling TJ, Allen BG, Nichols EM, Attia A, Zeng J, Biswas T, Paximadis P, Wang F, Walker JM, Stahl JM, Daly ME, Decker RH, Hales RK, Willers H, Videtic GM, Mehta MP, Lin SH.

Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):362-371. doi: 10.1016/j.ijrobp.2016.10.041. Epub 2016 Nov 2.

PMID:
28011047
30.

Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI.

Nie K, Shi L, Chen Q, Hu X, Jabbour SK, Yue N, Niu T, Sun X.

Clin Cancer Res. 2016 Nov 1;22(21):5256-5264. Epub 2016 May 16.

31.

Modern radiotherapy using image guidance for unresectable non-small cell lung cancer can improve outcomes in patients treated with chemoradiation therapy.

Deek MP, Kim S, Yue N, Baby R, Ahmed I, Zou W, Langenfeld J, Aisner J, Jabbour SK.

J Thorac Dis. 2016 Sep;8(9):2602-2609.

32.

Multi-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non-small cell lung tumors.

Verma V, Shostrom VK, Kumar SS, Zhen W, Hallemeier CL, Braunstein SE, Holland J, Harkenrider MM, S Iskhanian A, Neboori HJ, Jabbour SK, Attia A, Lee P, Alite F, Walker JM, Stahl JM, Wang K, Bingham BS, Hadzitheodorou C, Decker RH, McGarry RC, Simone CB 2nd.

Cancer. 2017 Feb 15;123(4):688-696. doi: 10.1002/cncr.30375. Epub 2016 Oct 14.

33.

Successes and Failures of Combined Modalities in Upper Gastrointestinal Malignancies: New Directions.

Jamorabo DS, Lin SH, Jabbour SK.

Semin Radiat Oncol. 2016 Oct;26(4):307-19. doi: 10.1016/j.semradonc.2016.05.001. Epub 2016 May 25. Review.

PMID:
27619252
34.

Modern induction chemotherapy before chemoradiation for bulky locally-advanced nonsmall cell lung cancer improves survival.

Ahmed I, Ferro A, Baby R, Malhotra J, Cohler A, Langenfeld J, Aisner J, Zou W, Jabbour SK.

J Cancer Res Ther. 2016 Apr-Jun;12(2):952-8. doi: 10.4103/0973-1482.177214.

35.

ACR Appropriateness Criteria® Borderline and Unresectable Pancreas Cancer.

Expert Panel on Radiation Oncology-Gastrointestinal, Small W Jr, Hayes JP, Suh WW, Abdel-Wahab M, Abrams RA, Azad N, Das P, Dragovic J, Goodman KA, Jabbour SK, Jones WE 3rd, Konski AA, Koong AC, Kumar R, Lee P, Pawlik TM, Herman JM.

Oncology (Williston Park). 2016 Jul;30(7):619-24, 627, 632. Review.

36.

Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non-Small Cell Lung Cancer.

Deek MP, Kim S, Ahmed I, Fang BS, Zou W, Malhotra J, Aisner J, Jabbour SK.

Am J Clin Oncol. 2018 Apr;41(4):362-366. doi: 10.1097/COC.0000000000000293.

37.

Gastrointestinal Cancers-Changing the Standard for Rectal Cancer and Establishing a New Standard for Liver Tumors.

Apisarnthanarax S, Chia-Hsien Cheng J, Jabbour SK, Liauw SL, Murphy JD, Chang DT.

Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):930-6. doi: 10.1016/j.ijrobp.2016.02.024. No abstract available.

PMID:
27302509
38.

Clinical characteristics and dose-volume histogram parameters associated with the development of pleural effusions in non-small cell lung cancer patients treated with chemoradiation therapy.

Deek MP, Nagarajan S, Kim S, Ahmed I, Paul S, Scher ED, Listo M, Chen A, Aisner J, Hussain S, Haffty BG, Jabbour SK.

Acta Oncol. 2016 Aug;55(8):1029-35. doi: 10.1080/0284186X.2016.1176248. Epub 2016 May 24.

39.

Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.

Chang JY, Jabbour SK, De Ruysscher D, Schild SE, Simone CB 2nd, Rengan R, Feigenberg S, Khan AJ, Choi NC, Bradley JD, Zhu XR, Lomax AJ, Hoppe BS; International Particle Therapy Co-operative Group Thoracic Subcommittee.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):505-16. doi: 10.1016/j.ijrobp.2016.01.036. Epub 2016 Jan 23. Review.

PMID:
27084663
40.

Improving Outcomes for Esophageal Cancer using Proton Beam Therapy.

Chuong MD, Hallemeier CL, Jabbour SK, Yu J, Badiyan S, Merrell KW, Mishra MV, Li H, Verma V, Lin SH.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):488-97. doi: 10.1016/j.ijrobp.2015.11.043. Epub 2015 Dec 14. Review.

PMID:
27084662
41.

Risk factors and management of oligometastatic non-small cell lung cancer.

Patel AN, Simone CB 2nd, Jabbour SK.

Ther Adv Respir Dis. 2016 Aug;10(4):338-48. doi: 10.1177/1753465816642636. Epub 2016 Apr 8. Review.

42.

Long-Term Bone Marrow Suppression During Postoperative Chemotherapy in Rectal Cancer Patients After Preoperative Chemoradiation Therapy.

Newman NB, Sidhu MK, Baby R, Moss RA, Nissenblatt MJ, Chen T, Lu SE, Jabbour SK.

Int J Radiat Oncol Biol Phys. 2016 Apr 1;94(5):1052-60. doi: 10.1016/j.ijrobp.2015.12.374. Epub 2016 Jan 5.

PMID:
27026312
43.

Radiation therapy in patients with left ventricular assist device: A case report and literature review.

Emerson LY, Deek MP, Almendral J, Jabbour SK.

Pract Radiat Oncol. 2016 Jul-Aug;6(4):e145-7. doi: 10.1016/j.prro.2015.12.003. Epub 2015 Dec 7. Review. No abstract available.

PMID:
27017262
44.

Motion and volumetric change as demonstrated by 4DCT: The effects of abdominal compression on the GTV, lungs, and heart in lung cancer patients.

Rasheed A, Jabbour SK, Rosenberg S, Patel A, Goyal S, Haffty BG, Yue NJ, Khan A.

Pract Radiat Oncol. 2016 Sep-Oct;6(5):352-359. doi: 10.1016/j.prro.2015.12.006. Epub 2015 Dec 19.

PMID:
26922698
45.

Early vs. Late Chemoradiation Therapy and the Postoperative Interval to Adjuvant Therapy Do Not Correspond to Local Recurrence in Resected Pancreatic Cancer.

Patel AA, Nagarajan S, Scher ED, Schonewolf CA, Balasubramanian S, Poplin E, Moss R, August D, Carpizo D, Melstrom L, Jabbour SK.

Pancreat Disord Ther. 2015 Jun;5(2). pii: 151. Epub 2015 Apr 2.

46.

Impact of race and tumor subtype on second malignancy risk in women with breast cancer.

Diab N, Clark G, Langer L, Wang Y, Hamlington B, Brzeskiewicz L, O'Shaughnessy J, Diab S, Jabbour SK.

Springerplus. 2016 Jan 6;5:14. doi: 10.1186/s40064-015-1657-4. eCollection 2016.

47.

Thoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer.

Deek MP, Benenati B, Kim S, Chen T, Ahmed I, Zou W, Aisner J, Jabbour SK.

Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):147-154. doi: 10.1016/j.ijrobp.2015.09.022. Epub 2015 Sep 25.

48.

Ambulatory pulse oximetry as a clinical aid for the diagnosis and treatment response of radiation pneumonitis.

Scher ED, Kim S, Deek MP, Ahmed I, Kothadia JP, Balasubramanian S, Aisner J, Goyal S, Jabbour SK.

Pract Radiat Oncol. 2015 Nov-Dec;5(6):e635-41. doi: 10.1016/j.prro.2015.08.003. Epub 2015 Aug 20.

PMID:
26547829
49.

Key New Studies in Gastric and Esophageal Cancer.

Chang DT, Jabbour SK, Brunner T, Cheng JC, Liauw SL, Meyer J, Wo J.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):475-81. doi: 10.1016/j.ijrobp.2015.05.045. No abstract available.

PMID:
26460987
50.

ACR Appropriateness Criteria® Local Excision in Early Stage Rectal Cancer.

Russo S, Blackstock AW, Herman JM, Abdel-Wahab M, Azad N, Das P, Goodman KA, Hong TS, Jabbour SK, Jones WE 3rd, Konski AA, Koong AC, Kumar R, Rodriguez-Bigas M, Small W Jr, Thomas CR Jr, Suh WW.

Am J Clin Oncol. 2015 Oct;38(5):520-5. doi: 10.1097/COC.0000000000000197. Review.

PMID:
26371522

Supplemental Content

Loading ...
Support Center